Product Information
STELARA 90 MG/ML SYRINGE is a brand product labeled by Janssen Biotech, Inc., priced at $29797.8880 per ML under NDC 57894006103. Its NADAC has been published 647 times since Nov 28, 2013.
Strength
90 mg/mL
Manufacturer
Janssen Biotech, Inc.NDC
57894006103
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
USTEKINUMABApproval Type
Biologic (BLA)
FDA Application
BLA125261On Market Since
9/25/2009
Pharmacological Classes
Price Statistics
The NADAC for STELARA 90 MG/ML SYRINGE has been published 647 times since Nov 28, 2013, and over the history we have for it it has risen 130.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $29797.8880 per ML |
|---|---|
| All-time high | $29797.8880 (Jun 24, 2026) |
| All-time low | $12951.1987 (Nov 28, 2013) |
| 52-week high | $29797.8880 |
| 52-week low | $28361.0058 |
| Median price | $22277.7100 |
| Average price | $21632.1356 |
| Largest weekly change | +10.4% (Aug 19, 2015) |
| Weeks tracked | 647 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ustekinumab market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of STELARA 90 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for STELARA 90 MG/ML SYRINGE, manufactured by Janssen Biotech, Inc., is $29797.8880 per ML (NDC 57894006103), effective Jun 24, 2026.
How has the price of STELARA 90 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for STELARA 90 MG/ML SYRINGE has risen 130.1%. It has been tracked across 647 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for STELARA 90 MG/ML SYRINGE?
Since Nov 28, 2013, the NADAC for STELARA 90 MG/ML SYRINGE has ranged from a low of $12951.1987 (Nov 28, 2013) to a high of $29797.8880 (Jun 24, 2026), with a median of $22277.7100 per ML.
Are there cheaper alternatives to STELARA 90 MG/ML SYRINGE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of STELARA 90 MG/ML SYRINGE, so no direct lower-cost alternative is listed.
Who manufactures STELARA 90 MG/ML SYRINGE?
STELARA 90 MG/ML SYRINGE (NDC 57894006103) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification